Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids
Kaydedildi:
Barocas, J.A., et al., Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids. International Journal of Drug Policy, vol. 72, 2019, p. 160-168.
Ref.
576285
Yer:
SIIS Archivo (R.1114)
Palabras clave:
Drogodependencias, Opiáceos, Buprenorfina
Drogodependencias, Opiáceos, Buprenorfina
İlk yorumlayan siz olun!